Heba Alkhatabi

Dr. Heba Alkhatabi


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 February 2022 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
MAMajid Alhomrani
Majid Alhomrani
WAWalaa F. Alsanie
Walaa F. Alsanie
AAAbdulhakeem Alamri
Abdulhakeem Alamri
HAHussain Alyami
Hussain Alyami
HHHamza Habeeballah
Hamza Habeeballah
AGAhmed Gaber
Ahmed Gaber
The aim of this study was to assess the utility of inexpensive techniques in evaluating the interactions of risperidone (Ris) with different traditional π-acceptors, with subsequent application of the findings into a Ris pharmaceutical formulation with improved therapeutic properties. Molecular docking calculations were performed using Ris and its different charge-transfer complexes (CT) with picric acid (PA), 2,3-dichloro-5,6-dicyanop-benzoquinon (DDQ), tetracyanoquinodimethane (TCNQ), tetracyano ethylene (TCNE), tetrabromo-pquinon (BL), and tetrachloro-p-quinon (CL), as donors, and three receptors (serotonin, dopamine, and adrenergic) as acceptors to study the comparative interactions among them. To refine the docking results and further investigate the molecular processes of receptor–ligand interactions, a molecular dynamics simulation was run with output obtained from AutoDock Vina. Among all investigated complexes, the [(Ris) (PA)]-serotonin (CTcS) complex showed the highest binding energy. Molecular dynamics simulation of the 100 ns run revealed that both the Ris-serotonin (RisS) and CTcS complexes had a stable conformation; however, the CTcS complex was more stable.

20 July 2016 in BMC Genomics
Verified
Journal Article
Open access
JSJerry W. Shay
Jerry W. Shay
NHNoriko Homma
Noriko Homma
RZRuyun Zhou
Ruyun Zhou
MNMuhammad Imran Naseer
Muhammad Imran Naseer
ACAdeel Chaudhary
Adeel Chaudhary
SBSaleh Binsaleh
Saleh Binsaleh
O1 Regulation of genes by telomere length over long distances

20 May 2022 in Molecules
Verified
Journal Article
Open access
PDF file
AAAbdulhakeem Alamri
Abdulhakeem Alamri
MAMajid Alhomrani
Majid Alhomrani
WAWalaa F. Alsanie
Walaa F. Alsanie
HAHussain Alyami
Hussain Alyami
SSSonam Shakya
Sonam Shakya
AGAhmed Gaber
Ahmed Gaber
Haloperidol (HPL) is a typical antipsychotic drug used to treat acute psychotic conditions, delirium, and schizophrenia. Solid charge transfer (CT) products of HPL with 7,7,8,8-tetracyanoquinodimethane (TCNQ) and picric acid (PA) have not been reported till date. Therefore, we conducted this study to investigate the donor–acceptor CT interactions between HPL (donor) and TCNQ and PA (π-acceptors) in liquid and solid states. The complete spectroscopic and analytical analyses deduced that the stoichiometry of these synthesized complexes was 1:1 molar ratio. Molecular docking calculations were performed for HPL as a donor and the resulting CT complexes with TCNQ and PA as acceptors with two protein receptors, serotonin and dopamine, to study the comparative interactions among them, as they are important neurotransmitters that play a large role in mental health. A molecular dynamics simulation was ran for 100 ns with the output from AutoDock Vina to refine docking results and better examine the molecular processes of receptor–ligand interactions. When compared to the reactant donor, the CT complex [(HPL)(TCNQ)] interacted with serotonin and dopamine more efficiently than HPL only. CT complex [(HPL)(TCNQ)] with dopamine (CTtD) showed the greatest binding energy value among all. Additionally, CTtD complex established more a stable interaction with dopamine than HPL–dopamine.

25 June 2016 in Oncotarget
Verified
Journal Article
Open access
HAHeba Alkhatabi
Heba Alkhatabi
DMDonal P. McLornan
Donal P. McLornan
AKAustin G. Kulasekararaj
Austin G. Kulasekararaj
FMFarooq Malik
Farooq Malik
TSThomas Seidl
Thomas Seidl
GMGhulam J. Mufti
Ghulam J. Mufti
RPL27A is a target of miR-595 and may contribute to the myelodysplastic phenotype through ribosomal dysgenesis

10 October 2016 in BMC Medical Genetics
Verified
Journal Article
Open access
PDF file
MGMamdooh Abdullah Gari
Mamdooh Abdullah Gari
MAMohammed AlKaff
Mohammed AlKaff
HAHaneen S. Alsehli
Haneen S. Alsehli
ADAshraf Dallol
Ashraf Dallol
AGAbdullah Gari
Abdullah Gari
MAMohammed M. Abbas
Mohammed M. Abbas
Osteoarthritis (OA) is a progressive joint disease characterized by gradual degradation of extracellular matrix (ECM) components in the cartilage and bone. The ECM of cartilage is a highly specified structure that is mainly composed of type II collagen and provides tensile strength to the tissue via aggrecan and proteoglycans. However, changes in the ECM composition and structure can lead to loss of collagen type II and network integrity. Several risk factors have been correlated with OA including age, genetic predisposition, hereditary factors, obesity, mechanical injuries, and joint trauma. Certain genetic association studies have identified several genes associated with OA using genome-wide association studies (GWASs). We identified several novel genetic variants affecting genes that function in several candidate causative pathways including immune responses, inflammatory and cartilage degradation such as SELP, SPN, and COL6A6. The approach of whole-exome sequencing can be a promising method to identify genetic mutations that can influence the OA disease.

1 August 2021 in Virology
Verified
Journal Article
Closed access
FNFatmah M A Naemi
Fatmah M A Naemi
SAShurooq Al-Adwani
Shurooq Al-Adwani
HAHeba Alkhatabi
Heba Alkhatabi
AAAshwaq Alnazawi
Ashwaq Alnazawi